Pages that link to "Q41201314"

The following pages link to (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate (Q41201314):

Displaying 11 items.

• 18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration (Q37552097) (← links)
• Role of 18F-FDG PET/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group (Q39214847) (← links)
• Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient. (Q47101932) (← links)
• Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation. (Q48089815) (← links)
• A predicting model of bone marrow malignant infiltration in 18F-FDG PET/CT images with increased diffuse bone marrow FDG uptake. (Q55284893) (← links)
• Diagnostic Applications of Nuclear Medicine: Multiple Myeloma (Q61755927) (← links)
• Clinical Applications of Nuclear Medicine: Multiple Myeloma (Q61755936) (← links)
• Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study (Q89338993) (← links)
• Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation (Q90582314) (← links)
• Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma (Q91863578) (← links)
• Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma (Q92442102) (← links)